Drug General Information (ID: DDI0E49YW8)
  Drug Name Entacapone Drug Info Ferrous fumarate Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antiparkinson Agents Iron Supplement
  Structure

 Mechanism of Entacapone-Ferrous fumarate Interaction (Severity Level: Moderate)
     Complex formation Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Entacapone Ferrous fumarate
      Mechanism Binds to polyvalent cations Polyvalent cations
      Key Mechanism Factor 1
Factor Name Chelation
Factor Description Chelation is a direct drug interaction that usually involves the formation of dimers or trimers, resulting in larger complexes and poorer absorption.
      Mechanism Description
  • Decreased absorption of Ferrous fumarate due to formation of complexes caused by Entacapone 

Recommended Action
      Management Patients receiving entacapone concomitantly with iron-containing products should be advised to separate the times of administration by 2 to 3 hours.

References
1 Product Information. Comtan (entacapone) Novartis Pharmaceuticals, East Hanover, NJ.